Herophilus

About:

Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.

Top Investors: Liquid 2 Ventures, Luxor Capital Group, Kinled Holding, 515 Ventures, KF Ventures

Description:

Herophilus helps cure brain diseases. They are discovering and reinventing neuro drugs by combining human brain models, scaled biology, and machine learning to systematically discover and develop novel drugs with therapeutic potential.

Total Funding Amount:

$16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Founders:

Frederic Kerrest, Frédéric Kerrest, Saul Kato, Sean Escola

Number of Employees:

11-50

Last Funding Date:

2021-01-05

IPO Status:

Private

Industries: